Ozempic Shortage Leaves Diabetic Patient Without Drug

Australia News News

Ozempic Shortage Leaves Diabetic Patient Without Drug
Australia Latest News,Australia Headlines
  • 📰 bbchealth
  • ⏱ Reading Time:
  • 26 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 14%
  • Publisher: 63%

A diabetic patient named John Hallam, 82, is facing difficulties in obtaining the necessary medicine, Ozempic, to manage his blood sugar due to a shortage. According to Diabetes UK, supplies of Ozempic are not expected to stabilize until mid-2024.

By Hayley Coyle & Becki ThomasA diabetic is struggling to get the medicine he needs to manage his blood sugar due to a shortage.It is part of a group of drugs recently popular with celebrities using it as a weight loss aid.

Mr Hallam, from Lincoln, has had type 2 diabetes for 33 years and said Ozempic was "vital and very beneficial" to him. "I feel very annoyed and frustrated that people can buy it privately and are denying people who rely on it," he told the BBC.GP David Sheehan, diabetes lead at Nettleham Medical Practice in Lincoln, said the group of drugs used to treat type 2 diabetes have become widespread among celebrities like Elon Musk, who has endorsed them as a weight loss aid.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

bbchealth /  🏆 143. in US

Australia Latest News, Australia Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Ozempic and Mounjaro makers sued by patient alleging ‘severe gastrointestinal issues'Ozempic and Mounjaro makers sued by patient alleging ‘severe gastrointestinal issues'The medications are used to treat Type 2 diabetes and have become popular weight-loss drugs.
Read more »

Patient Sues Ozempic and Mounjaro Makers Over Severe Gastrointestinal IssuesPatient Sues Ozempic and Mounjaro Makers Over Severe Gastrointestinal IssuesA patient from Louisiana has filed a lawsuit against Novo Nordisk, the maker of Ozempic, and Eli Lilly, the maker of Mounjaro, alleging that they failed to adequately warn about the potential adverse side effects of the medications, including the risk of gastroparesis.
Read more »

First came Ozempic for weight loss, then came the shaming.First came Ozempic for weight loss, then came the shaming.'The Real Housewives of Orange County' star reveals she was shamed for using the weight loss drug, Ozempic.
Read more »

The struggle is real for Asian foodies as sriracha shortage persistsThe struggle is real for Asian foodies as sriracha shortage persistsThe shortage of sriracha sauce is causing difficulties for Asian food lovers, as they are forced to buy from resellers who are charging double or triple the original price. Elisa Lee, a Korean American, is unable to find the sauce made by Huy Fong Foods, despite visiting multiple supermarkets in Pennsylvania and New Jersey.
Read more »

Colorado cancer centers face chemotherapy drug shortageColorado cancer centers face chemotherapy drug shortageColorado doctors are struggling to manage a shortage of chemotherapy drugs, leading to the need for drug substitutions and adjustments in dosing schedules. The shortage is attributed to manufacturing issues and high demand.
Read more »



Render Time: 2025-02-28 07:21:26